The Value of EEG in Stroke Units

ConditionEpilepsy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAttikon Hospital

About this trial

Τhe aim of the study is to investigate the role of EEG both in predicting epileptogenesis in patients with acute stroke and in detecting and clarifying the clinical significance of subclinical epileptic seizures in a stroke unit. More specifically, the performance of routine EEG in patients with ischemic or hemorrhagic stroke who are hospitalized in the Stroke Unit within the first days after the event, regardless of the presence of clinical indications, and the identification of risk factors for the early development of epilepsy in the course of these patients' disease constitute the central research question. The identification of patients with subclinical electroencephalographic seizures and the impact of such events on functional outcome, as well as their association with the development of epilepsy, are set as secondary research objectives.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Patients with acute ischemic or hemorrhagic stroke in whom it is not possible to perform an electroencephalogram within the first 7 days after the event, as well as patients who themselves or their legal representatives do not consent to participation, will be excluded from the study.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Routine EEG

    Other intervention

    The study is observational. No intervention is anticipated. Patients will be submitted to EEG recording within the first seven days of stroke

  • Routine EEG

    Other intervention

    The study is observational

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: Adult patients with acute ischemic or hemorrhagic stroke1 intervention

Trial outcomes

Primary outcomes

1

Incidence of post-stroke epilepsy

Time frame
4 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.